Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial Studying the Safety and Efficacy of Keppra® as Adjunctive Therapy in Adult Patients With Uncontrolled Partial Epilepsy

NCT00630968 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00630968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00630968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial Studying the Safety and Efficacy of Keppra® as Adjunctive Therapy in Adult Patients With Uncontrolled Partial Epilepsy
Lead sponsor
UCB Pharma
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2000
Completion date
February 29, 2004
Enrollment
1,541 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy